Alkem Laboratories Ltd
Manish Kumar possesses over 29 years of extensive experience in the pharmaceutical industry, currently serving as General Manager at Alkem Laboratories Ltd. since July 2014, managing an acute business of 650 Crore with a field force of 1025, overseeing a mix of heritage and newer brands. Prior roles include National Sales Manager at Alembic Pharmaceuticals Limited, and at IPCA Labs, handling significant business units, and a progressive career at Glaxo, Unichem, and Micro, where promotions were achieved within a six-year period. Manish holds a Bachelor of Science degree from KVS.
This person is not in any teams
This person is not in any offices
Alkem Laboratories Ltd
9 followers
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.